CONMED Corp — Director's Dealing 2012

Dec 17, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2012-12-14

Reporting Person: Darling Joseph G (President ConMed Linvatec)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-14	Common Stock	S	2000	$27.098	Disposed	2855	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.01 to $27.13. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed or a ConMed security holder.